Centene Stock – Fundamental Analysis

Price
70.16
10/14/2026
Dec 2001
Oct 2026

Fundamental Data & Ratios (Balance sheet update: 9/6/2026)

Balance Sheet Total Assets 76,747,000,000.00 ROE 26.00 %
Balance Sheet Total Equity 19,953,000,000.00 ROA -8.69 %
Cashflow Capital Expenditures -767,000,000.00 P/FCF 7.97
Cashflow Free Cash Flow 4,320,999,936.00 – –
Cashflow Operating Cash Flow 5,088,000,000.00 P/CF 6.77
Income Earnings per Share (diluted) -13.59 Div. Yield –
Income Net Income -6,673,000,000.00 P/E -5.16
Income Shares Outstanding 491,071,000.00 P/B 1.73
Income Total Revenue 194,777,000,000.00 P/S 0.18

Ratios calculated on: 10/14/2026

Company Description

Centene Corporation is a multi-line healthcare enterprise, which provides programs and services to the number of under-insured and uninsured individuals. The Company provides member-focused services through locally based staff by assisting in accessing care, coordinating referrals to related health and social services and addressing member concerns and questions. It also provides education and outreach programs to inform and assist members in accessing appropriate healthcare services. It combines its decentralized local approach for care with a centralized infrastructure of support functions, such as finance, information systems and claims processing. The Company operates in two segments: Medicaid Managed Care and Specialty Services. Effective April 1, 2013, it acquired Specialty Therapeutic Care Holdings Inc doing business as AcariaHealth.

Advanced Analysis Features

Additional comparison and history views are available after login.

Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.centene.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown. Learn more